OTCM
DOGP
Market cap1mUSD
Jul 09, Last price
0.01USD
1D
0.00%
1Q
-39.42%
Jan 2017
-99.85%
IPO
-99.18%
Name
Cannabis Sativa Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Cannabis Sativa, Inc., operating primarily through its various subsidiaries, offers online telemedicine referral services to individuals in the United States seeking medical marijuana cards. Its flagship platform, PrestoDoctor, is an online telemedicine service that enables users to connect virtually with physicians via video conferencing to secure medical cannabis recommendations. Beyond these core services, the company is also developing a diverse range of products. These include lozenges formulated for throat irritation relief; 'Recover,' a deep-penetrating healing balm designed to ease discomfort in sore muscles, joints, and conditions such as arthritis and back pain; 'Trauma Cream,' a topical blend infused with cannabinoids and THC; and a "Garden" line of skincare products featuring 'Face Garden' (an antioxidant moisturizing cream), 'Body Garden' (a moisturizing lotion), and 'Lip Garden' (an emollient balm). Additionally, Cannabis Sativa, Inc. markets branded merchandise, including men's and women's fashion t-shirts, sweatshirts, caps, and coffee mugs, under the 'Wild Earth Naturals' and 'hi' labels, available through its wildearthnaturals.com website. The company also holds intellectual property licenses pertinent to the manufacturing of medical marijuana edibles. Active within both the cannabidiol (CBD) and broader marijuana industries, Cannabis Sativa, Inc. was established in November 2013, having previously been known as Ultra Sun Corporation. The company is headquartered in Mesquite, Nevada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||